On April 14, 2025, exciting news spread through Hubei Xindesheng Company. The Department of Science and Technology of Hubei Province has officially announced the results of the 2025 Blood Innovation Platform assessment. Hubei Xindesheng Material Technology Co., Ltd. achieved an amazing cross level comeback from "failing" to "excellent" in the 2023 assessment with an excellent comprehensive score of A+, becoming the only enterprise in the province to receive this honor. At the same time, Xindesheng has also been awarded the title of one of the few innovative excellent enterprises in Ezhou City. This major breakthrough is of great significance, not only marking the company's upgrade in the field of blood technology research and development and industrial transformation, but also demonstrating its surging driving force for innovative development.

A magnificent turnaround from 'failing' to 'excellent'

1. The determination and action of self-renewal: Looking back at the evaluation results of 2023, Xindesheng did not give up because of this, but instead used it as an opportunity to stimulate a strong determination for self-renewal within the company. The company quickly established a professional rectification team to conduct in-depth analysis of the problems in research and development, management, and achievement transformation. In the R&D process, the project initiation, experimental design, data monitoring and other links have been optimized, and advanced project management software has been introduced to ensure the progress of R&D projects. In terms of talent cultivation, we have increased our internal training efforts, regularly inviting experts from universities for technical guidance and training, while actively introducing external talents to enhance the strength of our R&D team. Through a series of practical actions, New Desheng has laid a solid foundation for achieving a comeback.

2. Continuous investment and strategic adjustment: In order to enhance its technological innovation capabilities, Xindesheng has continuously increased its research and development investment in the past two years. The company has invested a large amount of funds in the upgrading of laboratory equipment, purchasing advanced analytical instruments, automated synthesis equipment, etc., providing reliable hardware support for research and development work. In terms of strategic planning, the company focuses on the field of blood technology research and development and industrial transformation, clarifying its development direction. Conduct in-depth research on market demand, adjust research and development priorities in a timely manner based on market feedback, and develop a series of products that better meet market demand.

Hubei Province has been awarded the Excellent Level, demonstrating its hardcore strength

Desheng New Materials has achieved an excellent score of A+in comprehensive evaluation, which not only recognizes the scientific research strength of Desheng New Materials, but also affirms the team's spirit of hard work.  

1. Industry recognition, industry benchmark: The Hubei Provincial Department of Science and Technology highly praised the progress of New Desheng in the evaluation report, pointing out that it has performed excellently in technological innovation, industrial landing, social contribution, and set an example.  

2. Key supported enterprises in Ezhou City: As a key technology enterprise cultivated by Ezhou City, Xindesheng has been awarded the "Excellent" level, further consolidating its core position in the regional scientific and technological innovation system. In the future, Ezhou will continue to provide support in policies, funding, talent, and other aspects to help enterprises move towards higher levels.  

Taking this assessment as a new starting point, Xindesheng will continue to adhere to the innovation driven development strategy. Continuously increasing research and development investment, constantly exploring new technologies and methods, committed to developing more core technologies and products with independent intellectual property rights. In the field of blood technology research and development, further in-depth research is needed to expand product application areas.

New Desheng has completed a magnificent transformation in just two years, which cannot be achieved without the hard work of all employees, the strong support of partners, and policy support. In the future, Xindesheng will continue to take innovation as the engine, market orientation, and social responsibility as its responsibility, leading the way in the blood health industry and making greater contributions to the scientific and technological innovation and career development of Hubei Province!